CD274 and cancer: Immunoassays leverage the high affinity and specificity of antibodies to detect even trace amounts of specific biomarkers, making them essential tools in diagnostics, including the detection of cancer biomarkers, such as programmed cell death ligand 1 (PDL1) and human epithelial growth factor receptor 2 (HER2) [1,2,3,4].